Pfizer Sales Miss Expectations

Pfizer’s sales continued to fall in the second quarter as its drugs faced increased competition from biosimilars, but the company still gave a rosy earnings outlook for the year.

from WSJ.com: US Business http://ift.tt/2uUzpcJ
via IFTTT